English | Español

Regulatory
+ Regulatory
Patient Daily | Sep 17, 2025

PhRMA’s Senior Director on 340B: 'State and federal investigations have shown 340B is often exploited for profit'
+ Marketing
Patient Daily | Sep 17, 2025

Patients Come First spokesperson: Drug ads 'are putting lives at risk by encouraging people to abandon essential treatments'
+ Pharmaceuticals
Patient Daily | Sep 17, 2025

Baylor College of Medicine expert discusses updated flu vaccines ahead of upcoming season
+ Pharmaceuticals
Patient Daily | Sep 16, 2025

Baylor receives $5.9M grant for Houston Nutrition and Obesity Research Center
+ Pharmaceuticals
Patient Daily | Sep 16, 2025

Cleveland Clinic sponsors annual LUNG FORCE Walk in partnership with American Lung Association
+ Pharmaceuticals
Patient Daily | Sep 16, 2025

Health groups ask EPA not to repeal vehicle greenhouse gas standards
+ Pharmaceuticals
Patient Daily | Sep 16, 2025

Study finds exercise-produced molecule may help reduce appetite through brain pathways
Patient Daily | Sep 15, 2025

Physician assistant on sinus issues and sleep disruption: ‘Any kind of sinus issue will always affect your sleep’

Trending
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
Patient Daily reports | Aug 10, 2026

SoCal Breathe Free warns persistent sinus symptoms may signal chronic inflammation
+ Regulatory
M. Y. Bailey | Aug 7, 2026

PhRMA's Zirkelbach: 340B program has changed dramatically with 'little transparency into how patients benefit'
+ Pharmaceuticals
Patient Daily | Aug 7, 2026

Researchers develop computer model linking brain chemistry to neural activity patterns